Category

Description

Company Summary

VL58, Inc. is a privately held, early-stage biotechnology company developing a novel approach to gene editing and gene therapy that can address diseases that are untreatable with current approaches like CRISPR or AAVs.

VL58 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 40 groundbreaking companies over the past fifteen years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Seres Therapeutics (NASDAQ:MCRB), Moderna, Syros Pharmaceuticals (SYRS), Rubius Therapeutics (RUBY), Axcella Health, Evelo Biosciences (EVLO), and Indigo Agriculture.

Position Summary

The Research Associate will be responsible for the supporting the team through execution and development of various molecular assay protocols. This individual will join a dynamic, rapidly growing, and highly collaborative team that combines significant biologic drug discovery experience with pioneering discoveries driving a novel biological platform.

Key Responsibilities

• The successful candidate will work both independently and as part of a collaborative team to design, plan and execute experiments that support research activities, project goals, and platform develop.
• Next-generation sequencing library preparation
• Quantitative PCR
• ELISA
• Assay development
• Design, execution, and troubleshooting of experiments as well as data analysis
• Maintaining lab notebooks and reporting data and analysis results to the scientific team

Preferred Qualifications

• Bachelor

Get In Touch